Axovant Focuses on Gene Therapy with Benitec Partnership
By Michelle Liu
Pharma Deals Review: Vol 2018 Issue 7 (Table of Contents)
Published: 26 Jul-2018
DOI: 10.3833/pdr.v2018.i7.2338 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Following its recent disappointment with intepirdine in Alzheimer’s disease, Axovant was keen to rebuild its neuroscience pipeline by focusing on gene therapy and entered into an agreement with Australian biotech, Benitec...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS